' Introduction
Despite advances in detection, treatment, and long-term care for survivors, cancer is the second most common cause of death in the United States. 1 Among children and adolescents, cancer is the most common cause of nonaccidental death, with central nervous systems being the second most common site of involvement. 1 Brain and central nervous system tumors are the most common solid tumor among children 0 to 14 years of age. 2, 3 The incidence of malignant central nervous system tumors in children and adolescents (aged birth to 19 y) has increased over the period of time between 2000 and 2008. 4 It is estimated that for the year 2018, 4610 children and young adults will have been diagnosed with a new brain or central nervous system neoplasm. 3 However, survival rates have been improving, likely due to a combination of new treatment modalities, improved surveillance methods for recurrence, improved surgical techniques and radiation therapies, as well as risk-adapted chemotherapeutic regimens. 5, 6 As children are more often transferring care to long-term survivorship clinics outcome measures are also moving toward quality of life measures, and beyond survival alone. 7, 8 Treatment decisions for pediatric central nervous system tumor patients are often made by a multidisciplinary team, which may include the neuro-oncologist, neuroradiologist, neuro-ophthalmologist, neurosurgeon, and pediatric neurologist. Accurate data on visual function in a young, sick child may be difficult to obtain, but obtaining the highest quality data is important as treatment decisions may be made based on the observations of the ophthalmologist.
Involvement of the ophthalmologist in care of the pediatric central nervous system tumor patient should be standard of care. Early assessment of the visual system in these children may not be performed for many reasons, including lack of awareness of providers of the potential involvement of the visual system despite lack of direct involvement of the tumor in the primary visual pathways. Other limitations to obtaining a timely ophthalmologic examination include the difficulty in examining an acutely ill child, priority given to treatment of the primary lesion rather than sequelae of the lesion, inability of a young child to clearly communicate symptoms of vision loss or abnormal visual symptoms, and lack of access to an ophthalmologist or neuro-ophthalmologist. Brain tumors can alter the normal anatomy of structures involved in both the afferent and efferent visual systems, leading to dysfunction of these systems, vision loss, and ocular motility disturbances. The signs, symptoms, and examination techniques to evaluate these alterations will be discussed. ' 
Demographics
The incidence of childhood cancers has been gradually increasing. About 6% of all central nervous system tumors reported between 2010 and 2014 occurred in children and young adults (ages 0 to 19). 2 Tumors of the brain parenchyma (temporal lobe, frontal lobe, parietal lobe, and occipital lobe) were most common (16.7%) followed by neoplasms of the pituitary and craniopharyngeal duct (15.6%), cerebellum (13%), brain stem (11%), cranial nerves (7.1%), and ventricle (5.7%).
2 Younger children were more likely to have cerebellar tumors, whereas adolescents were more likely to have involvement of the pituitary gland and craniopharyngeal duct.
2 Children 14 years of age and younger were most likely to have pilocytic astrocytomas (18.2%), malignant gliomas (13.9%), and embryonal tumors (13.5%). Adolescents most commonly had pituitary and craniopharyngeal duct tumors (32.1%). 2 
' Visual System in Children
The visual system of a child is still developing, and this puts children with central nervous system tumors at particular risk of vision loss from failure to develop normally. The continued development of the visual system must be taken into account when assessing vision in the ophthalmic examination, as normal visual acuities vary by age. If evaluated with visual-evoked potentials, the Snellen visual acuity equivalent of a newborn is ∼20/200, and approaches 20/40 by 6 months to 1 year of age. 9 Visual fields rapidly mature after birth, and they continue to mature throughout childhood. The fovea also matures after birth, until ∼15 to 45 months of age. 9 The occipital cortex continues to develop and retains plasticity through ∼8 years of age. Visual input from each eye is essential for monocular and binocular visual development, and interruption of the visual input from 1 eye from occlusion, strabismus, or refractive error can lead to amblyopia, which if left untreated can lead to permanent vision loss. Children with central nervous system tumors are at risk for having strabismus or ptosis, as discussed below, and therefore may be at higher risk for the development of amblyopia in addition to the risk of visual pathway damage from their underlying tumor. In addition, posttreatment cataracts can lead to deprivation amblyopia. ' 
Signs and Symptoms of Brain Tumors in Children
Symptoms of brain tumors in children may be entirely nonspecific. For example, very young children may present with signs of irritability, lethargy, anorexia, and psychomotor regression. 10 However, a combination of signs and symptoms may lead to high suspicion of an intracranial lesion.
Effects on the afferent visual pathways include visual field defects from parenchymal brain lesions, involvement of the lateral geniculate ganglion, optic tracts, optic chiasm, or optic nerves themselves. Compressive lesions including, and anterior to, the lateral geniculate ganglion result in optic atrophy. Papilledema (optic nerve head swelling from elevated intracranial pressure) can develop in cases of intracranial tumors as a result of mass effect with increased total brain volume, brain edema, invasion or obstruction of the venous sinus system, meningeal involvement by the tumor, or due to obstructive hydrocephalus. Early papilledema can produce peripheral visual field defects while preserving central vision. Chronic papilledema can lead to permanent, severe vision loss, including loss of peripheral vision and central vision. Optic neuropathy and optic atrophy from chronic papilledema can be from progressive loss of axonal nerve fibers, central retinal artery occlusion, or central retinal vein occlusion. Retinopathy and maculopathy can occur in cases of subretinal macular edema, choroidal folds, retinal nerve fiber layer hemorrhages, infarcts, and exudates. [11] [12] [13] A meta-analysis of cohort studies evaluated the presenting signs and symptoms of children with central nervous system tumors and found that, in addition to symptoms of increased intracranial pressure (headache, nausea, and vomiting), papilledema was present in 13% of patients evaluated, strabismus was present in 7%, cranial nerve palsies were present in 7%, and 6% had abnormal eye movements. 14 Location of the tumor can affect which symptoms and signs are present, though papilledema and elevated intracranial pressure can be present with any tumor location. 14 Alswaina and colleagues highlighted the important role of the ophthalmologist in making the diagnosis of a brain tumor in children, with 46% of these patients presenting with optic nerve atrophy, 46% with vision loss, 24% with papilledema, 24% with nystagmus, 19% with sixth nerve palsies, and 12% with a third nerve palsy. 15 Many of these children had multiple ocular findings. Presentation frequently included optic nerve edema or pallor with decreased vision or strabismus.
A retrospective chart review of patients presenting to the emergency room who were diagnosed with brain tumors evaluated their presenting signs and symptoms. 16 Headache was the most frequent symptom (67%), with 20% of patients presenting with vision changes. 16 Signs on examination included 23% of patients with cranial nerve deficits, 6% with ptosis, and 1% with anisocoria. Significantly, 13% of patients presented with papilledema; however, only 57% of patients were examined for the presence of papilledema. 16 This emphasizes the importance of performing funduscopic examination on all patients who present with headache and signs of increased intracranial pressure to the emergency room. ' 
Visual Outcomes of Children With Brain Tumors
Central nervous system neoplasms can affect both afferent and efferent visual systems, and treatment can affect the ocular structures as well. Adult survivors of pediatric brain tumors were found to have a relative risk of cataracts of 11.9 compared with their nonaffected siblings, a relative risk of legal blindness in one or both eyes of 14.8, and a relative risk of diplopia of 8.8. 17 An analysis of 10 children presenting to a neuro-ophthalmology clinic who underwent surgical intervention for an intracranial neoplasm found that of the 8 children who had preoperative ophthalmological examinations, all but one had significant reductions in vision before their surgeries. 18 Postoperatively all 10 children had optic atrophy and vision loss, and 8 had strabismus. 18 Four of those patients experienced vision loss in the perioperative period. 18 Craniopharyngiomas commonly cause vision loss as a consequence of the close proximity of the remnants of Rathke's pouch, from which the tumor is thought to arise, to the optic chiasm, optic nerves, and optic tracts. As a result craniopharyngiomas can cause optic neuropathies and chiasmal syndromes (Fig. 1) . In addition, the foramen of Munro can become obstructed, leading to papilledema and hydrocephalus. In a review of 59 patients with craniopharyngioma 10% were found to meet the criteria for legal blindness, and 58% had some degree of visual impairment, highlighting the severe nature of vision loss secondary to craniopharygiomas. 19 Risk factors for vision loss included younger age at diagnosis, presence of optic nerve edema at presentation, and tumor recurrence. 19 A retrospective chart review of 20 children with pineal tumors found a 5% rate of optic atrophy, and 5% rate of the development of a homonymous hemianopia. 20 Another retrospective study of 29 children presenting with pineal tumors found similar results, with 4% having a visual field defect, and no patients with decreased vision at final follow-up. 21 Papilledema was present in 69% of patients. 21 Peeler and colleagues found that patients who had posterior fossa tumors (medulloblastoma, juvenile pilocytic astrocytoma, and ependymoma, most frequently) had rates of fair to poor visual acuities Figure 1 . A 10-year-old girl presented with headaches, diplopia, nausea, and vomiting. Sagittal T1-weighted postgadolinium with fat suppression magnetic resonance image (A) and coronal T1-weighted postgadolinium with fat suppression image (B) revealed a large solid and cystic suprasellar mass resulting in obstructive hydrocephalus and compression of the optic chiasm. Ophthalmologic examination revealed bilateral sixth nerve palsies and moderate papilledema, which can be seen on the axial fluid attenuation inversion recovery postcontrast image (C, arrows). The patient underwent resection, and pathology returned consistent with craniopharyngioma. Compression of the optic chiasm led to a bitemporal hemianopia (D). Papilledema and compression of the optic chiasm led to eventual optic nerve pallor with peripapillary changes (E) after resolution of the disc edema.
(defined as 20/40 or worse) following treatment of their underlying lesion of 17.2% 22 (Fig. 2 ). Kedar and colleagues evaluated the causes and locations of lesions leading to homonymous hemianopias in 86 children, and found that tumors caused 27% of all cases of pediatric homonymous hemianopias in comparison to 10% in adults. 23 This rate is similar to the 39% of pediatric homonymous hemianopias caused by neoplasms that Liu and Galetta 24 found in their series of 36 children. Importantly Harbert et al 25 found that 15.2% of children previously diagnosed with a primary brain tumor had unrecognized visual fields defects that were later (up to 13 y later) discovered on systematic neuro-ophthalmic examination. The most common tumor type causing an unrecognized visual field defect was a juvenile pilocytic astrocytoma, and the most Figure 2 . A 9-year-old boy presented with headaches, nausea, vomiting, and imbalance. Sagittal T1-weighted postgadolinium magnetic resonance image (A) and axial T1-weighted postgadolinium image (B) showed a large posterior fossa mass with obstructive hydrocephalus and transependymal cerebrospinal fluid flow on axial FLAIR postgadolinium image (C). Resection of the mass was performed and pathology returned consistent with medulloblastoma. Outpatient neuro-ophthalmologic examination several months after treatment showed visual acuities of hand motions OD and 20/125 OS, with severe bilateral optic nerve pallor (D), and diffuse visual field depression OD worse than OS with a retained central and paracentral island OS (E). Optical coherence tomography revealed diffuse RNFL loss OU (F), as well as diffuse GCL complex loss (G). He also had see-saw nystagmus and a right hypertropia thought to be due to a skew deviation. c/d indicates cup-to-disc; FLAIR, fluid attenuation inversion recovery; GCL, ganglion cell layer complex; IPL, inner plexiform layer; ONH, optic nerve head, RNFL, retinal nerve fiber layer. frequent locations were temporal lobe lesions and hemispheric lesions. 25 As many of these children become adolescents and adults, their visual field defects may affect their ability to drive, and the discovery of an unrecognized visual field defect may come as a shock to these children and their parents. This makes the systematic ophthalmologic evaluation of children with primary brain tumors even more important. Although patients with pineal tumors can develop afferent visual system dysfunction, more commonly these patients develop disorders of ocular motility, including some element of Parinaud syndrome (upgaze palsy, convergence-retraction nystagmus, light-near dissociation of pupils, and lid retraction) in all patients, horizontal deviations in 25%, and skew deviation in 15%. 20 Hankinson et al 21 found a 62% prevalence of Parinaud syndrome at final follow-up in their study of 29 pineal tumor patients. Similarly, while patients with posterior fossa tumors can develop decreased vision, likely from optic atrophy from chronic papilledema and hydrocephalus, these patients are at higher risk of efferent visual pathway disorders. 26 Patients who underwent treatment of posterior fossa lesions developed nystagmus (23%), and strabismus (42%). 22 A significant number underwent strabismus surgery to improve ocular alignment (17%). 22 Shalev and Repka 27 found in a cohort of 23 children with brain tumors who had strabismus that 60% were restored to orthotropia after either treatment of the tumor itself, or strabismus procedures (9/23). The authors suggest that restoration of binocular vision is possible with surgical intervention. Treatment plans should be tailored to the individual patient, as some patients may be at high risk for short-term clinical deterioration from their underlying central nervous system tumor.
Treatment of the tumor itself can lead to dysfuction of the visual system. Direct surgical trauma to the visual apparatus is possible, as is creating a visual field defect due to surgical approach to the tumor. Perioperative vision loss is also possible due to a sudden decrease in intracranial pressure, or interruption of the blood supply of the optic nerves. Radiotherapy can damage the visual pathways, either from late necrosis, or radiation-induced optic neuropathies, usually 5 months to 7 years after treatment. [28] [29] [30] Lower rates of radiation optic neuropathies are found when reducing the treatment dose to <50 Gy total dose and <8 Gy for a single dose. 31 Reports of chemotherapy leading to optic neuropathy, optic neuritis, papilledema, maculopathy, cataracts, keratitis, dry eye, retinal detachment, myasthenia gravis, inflammatory orbitopathy, retinopathy, cranial nerve palsies, and uveitis have been described. [32] [33] [34] [35] [36] [37] [38] [39] [40] ' Quality of Life for Pediatric Brain Tumor Survivors Vision loss, strabismus, and diplopia can be devastating and lead to long-term effects on quality of life for a child, and the child's family. Survivors of pediatric brain tumors have lower health-related quality of life scores compared with other cancer survivors and healthy patients. 41, 42 For example, vision loss can lead to decreased quality of life due to poor self-perception, school difficulties, driving ineligibility, and decreased access to gainful employment. 43 A study evaluating the long-term effects of brain tumors on children and health-related quality of life found that only 57% of survivors had a driver's license and were eligible to drive. 44 Decreased visual acuities are associated with decreased total quality of life scores, and children with visual impairment have 35.6% lower quality of life scores in comparison to age-matched controls. 43 Survivors of pediatric astroglial tumors were 4.7 times more likely to unmarried, 3.1 times more likely to live with a caregiver, and 2.2 times more likely to be unemployed if they were bilaterally blind in comparison to survivors without visual impairment. 45 Visual pathway disorders are associated with lower quality of life scores than abnormalities of the eye itself. 46 Jariyakosol and Peragallo reviewed studies evaluating quality of life in children with vision loss from brain tumors, and found that most health-related quality of life evaluations showed lower scores for patients who reported vision abnormalities in comparison to controls and patients without vision abnormalities. 7 Vision-related quality of life evaluations have thus far only been used in the pediatric population in a study of children with optic pathway gliomas. 47 Quality of life evaluations will likely become more important in evaluating children with brain tumors as more of these children survive their primary disease process and enter adolescence and adulthood. ' 
Examination of Children With Central Nervous System Neoplasms
Maximizing the information regarding visual pathway status in the presence of a central nervous system neoplasm is essential. Visual acuities are considered to be the most important measurable ophthalmic endpoint of pediatric brain tumors. 48, 49 Vision in infants can be assessed by reaction to light (blinking, withdrawal, pupil constriction). The ability to fixate may develop around 4 to 6 weeks of age, and following objects begins around 2 to 4 months of age. The "central, steady, maintained" method can be used for cooperative infants. Teller preferential looking cards can be used for cooperative infants for a quantitative measure of vision in preverbal children, and are the preferred method for quantitative assessment of vision in this age group. 49 Older children can be evaluated using HOTV or Lea symbol matching, followed by reading age-appropriate eye charts. Color vision can be assessed using pseudoisochromatic plates or a red cap for color desaturation. Pupil assessment is essential for detecting relative afferent pupillary defects. The extraocular motility examination should include ductions and versions, as well as alignment testing, again dependent on age. Slit-lamp examination, funduscopy, and a basic cranial nerve examination should be performed. Visual field testing can be more difficult in very young children, but attempts should be made with confrontation with interesting objects in the quadrants of the peripheral field of vision while maintaining fixation on a central target for the youngest children, with saccadic movements toward the introduced peripheral object counted as positive responses. Older Vision in Pediatric Brain Tumors ' 91 www.internat-ophthalmology.com children can perform more traditional finger counting as a basic test of visual fields. More cooperative children can perform kinetic perimetry, and eventually automated perimetry. Optic nerve photographs can be useful for serial monitoring of optic nerve atrophy or edema. Optical coherence tomography (OCT) is a useful adjunctive test for monitoring children with central nervous system neoplasms. Bialer et al 50 described a correlation of visual acuity and visual field defects with retinal nerve fiber layer thickness in children with craniopharyngioma. Hand-held OCT has been used to distinguish between optic pathway glioma patients with vision loss, and those without vision loss, and can be performed on children who are sedated for their serial magnetic resonance imaging. 51 Ganglion cell layer complex analysis of macular OCT scans can show thinning that suggests a compressive optic neuropathy, correlates with visual fields, and can potentially be useful as an adjunctive test for evaluating and monitoring brain tumor patients. 52 
' Conclusions
Survival rates for pediatric central nervous system tumors continue to improve with time. However, pediatric central nervous system tumors can lead to devastating long-term consequences for patients due to vision loss, ocular motor abnormalities, and decreased quality of life. Awareness of the potential for ophthalmic monitoring for progression and the opportunity to intervene to prevent vision loss from tumor involvement is important for the ophthalmologist and the multidisciplinary team caring for the patient. Involvement of the ophthalmologist in systematic treatment monitoring and decision-making is essential for optimal outcomes. Through earlier interventions the ophthalmologist may be able to improve long-term vision outcomes and quality of life.
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